ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease N Colombo, C Sessa, A Du Bois, J Ledermann, WG McCluggage, ... Annals of Oncology 30 (5), 672-705, 2019 | 1038 | 2019 |
Contribution of whole-body 18FDG PET imaging in the management of cervical cancer T Belhocine, A Thille, V Fridman, A Albert, L Seidel, P Nickers, F Kridelka, ... Gynecologic oncology 87 (1), 90-97, 2002 | 177 | 2002 |
Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic-FRANCOGYN group for the CNGOF C Akladios, H Azais, M Ballester, S Bendifallah, PA Bolze, N Bourdel, ... Journal of gynecology obstetrics and human reproduction 49 (6), 101729, 2020 | 112 | 2020 |
Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase B Detry, C Erpicum, J Paupert, S Blacher, C Maillard, F Bruyère, ... Blood, The Journal of the American Society of Hematology 119 (21), 5048-5056, 2012 | 106 | 2012 |
A clinical and pathological overview of vulvar condyloma acuminatum, intraepithelial neoplasia, and squamous cell carcinoma B Léonard, F Kridelka, K Delbecque, F Goffin, S Demoulin, J Doyen, ... BioMed research international 2014, 2014 | 80 | 2014 |
Circulating microRNA-based screening tool for breast cancer P Frères, S Wenric, M Boukerroucha, C Fasquelle, J Thiry, N Bovy, ... Oncotarget 7 (5), 5416, 2016 | 59 | 2016 |
Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors J McGee, M Bookman, P Harter, C Marth, I McNeish, KN Moore, A Poveda, ... Annals of Oncology 28 (4), 702-710, 2017 | 57 | 2017 |
High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma M Arafa, F Kridelka, V Mathias, JF Vanbellinghen, I Renard, JM Foidart, ... Histopathology 53 (5), 525-532, 2008 | 57 | 2008 |
Adjuvant small field pelvic radiation for patients with high risk, Stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection: A … FJ Kridelka, DO Berg, M Neuman, LS Edwards, G Robertson, PT Grant, ... Cancer 86 (10), 2059-2065, 1999 | 56 | 1999 |
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup I Vergote, A Gonzalez-Martin, D Lorusso, C Gourley, MR Mirza, JE Kurtz, ... The Lancet Oncology 23 (8), e374-e384, 2022 | 52 | 2022 |
The pre-metastatic niche in lymph nodes: formation and characteristics L Gillot, L Baudin, L Rouaud, F Kridelka, A Noël Cellular and Molecular Life Sciences 78 (16), 5987-6002, 2021 | 47 | 2021 |
[18F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation M Ferreira, P Lovinfosse, J Hermesse, M Decuypere, C Rousseau, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 3432-3443, 2021 | 44 | 2021 |
Vulvar skin disorders throughout lifetime: about some representative dermatoses J Doyen, S Demoulin, K Delbecque, F Goffin, F Kridelka, P Delvenne BioMed research international 2014, 2014 | 44 | 2014 |
Unique recurrence patterns of cervical intraepithelial neoplasia after excision of the squamocolumnar junction M Herfs, J Somja, BE Howitt, M Suarez‐Carmona, G Kustermans, ... International journal of cancer 136 (5), 1043-1052, 2015 | 43 | 2015 |
Stereotaxic needle-core biopsy and fine-needle aspiration biopsy in the diagnosis of nonpalpable breast lesions: controversies and future prospects E Lifrange, F Kridelka, C Colin European journal of radiology 24 (1), 39-47, 1997 | 43 | 1997 |
Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: a mono-institutional … F Lakosi, M de Cuypere, P Viet Nguyen, N Jansen, B Warlimont, ... Acta oncologica 54 (9), 1558-1566, 2015 | 41 | 2015 |
Optimal treatment in locally advanced cervical cancer C Gennigens, M De Cuypere, J Hermesse, F Kridelka, G Jerusalem Expert Review of Anticancer Therapy 21 (6), 657-671, 2021 | 39 | 2021 |
Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis S Guenin, M Mouallif, R Deplus, X Lampe, N Krusy, E Calonne, ... Public Library of Science 7 (8), e42704, 2012 | 36 | 2012 |
A specific immune and lymphatic profile characterizes the pre-metastatic state of the sentinel lymph node in patients with early cervical cancer C Balsat, S Blacher, M Herfs, M Van de Velde, N Signolle, P Sauthier, ... Oncoimmunology 6 (2), e1265718, 2017 | 35 | 2017 |
Current concepts in the pathology and epigenetics of endometrial carcinoma M Arafa, J Somja, P Dehan, F Kridelka, F Goffin, J Boniver, P Delvenne Pathology-Journal of the RCPA 42 (7), 613-617, 2010 | 34 | 2010 |